A Multi-Dose Study to Assess Tolerability, Safety and Pharmacology of hGH-ViaDerm™ System in Adults With GH-Deficiency

Clinical trial NCT00455260 · COMPLETED

Trial details

NCT number: NCT00455260
Sponsor: Teva Neuroscience, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Growth Hormone Deficiency

Start date: 2007-04-01
Primary completion: 2007-10-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.